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ABSTRACT
Q fever is a zoonotic disease caused by Coxiella bur-
netii. The pathogen is prevalent in ruminants (goats, 
sheep, cows), which are the main sources of human in-
fection. In the cattle industry around the world, animal 
(15 to 20%) and herd (38 to 72%) level prevalences of 
C. burnetii are high. Vaccination of ruminants against 
Q fever is considered important to prevent spreading of 
the disease and risk of infection in humans. However, 
published information on side effects of the Q fever 
vaccination under field conditions is limited for cows. 
The objective of this study was to investigate the effect 
of the phase I C. burnetii inactivated vaccine Coxevac 
on body temperature and milk yield in dairy cows. In 2 
experiments, a total of 508 cows were randomly divided 
into 2 groups to determine the effect of first vaccination 
on body temperature and milk yield. The C. burnetii 
serostatus of all cows was tested before vaccination 
with an indirect ELISA. The first experiment took 
place in the teaching and research barn of the Clinic of 
Animal Reproduction at the Freie Universität Berlin. 
Temperature was measured vaginally in 10 cows in a 
crossover design. The second experiment was conducted 
on a commercial dairy farm. Milk yield of 498 cows was 
measured 1 wk before and 1 wk after vaccination. In 
a subset of 41 cows, temperature was measured rec-
tally. In both experiments, body temperature increased 
significantly after vaccination (1.0 ± 0.9°C and 0.7 ± 
0.8°C). A significant difference was also found in body 
temperature between vaccinated and control cows. 
Thirty percent of the vaccinated animals in experiment 
1 showed reversible swelling at the injection site as a 
reaction to the vaccination. The results indicate that 
vaccination against Q fever causes a transient increase 
of body temperature that peaks in the first 12 to 24 
h and declines after that. In experiment 2, vaccinated 
cows (26.8 ± 0.39 kg/d) produced significantly less 
milk than did control cows (28.2 ± 0.44 kg/d) 7 d after 
first vaccination. The cumulative milk loss after first 
vaccination was influenced by an interaction between 
C. burnetii serostatus and average milk yield 7 d before 
first vaccination. This was considered as part of the 
physiological immune response. Three out of 10 vacci-
nated animals in experiment 1 showed painful swelling 
of the skin at the injection site, which had a maximum 
size of 14.0 × 14.0 × 1.1 cm. In conclusion, a transient 
increase of body temperature and a decrease in milk 
yield is prevalent after Coxevac vaccination.
Key words: Coxiella burnetii, Q fever, vaccination, 
body temperature
INTRODUCTION
Q fever is a zoonotic disease prevalent worldwide 
that is caused by the gram-negative bacterium Coxiella 
burnetii. Coxiella burnetii has the capacity to produce 
spores that are exceptionally resistant to physico-
chemical factors (Bielawska-Drózd et al., 2013), thus 
surviving well in the environment. It is well known 
that domestic ruminants are the major reservoirs of 
C. burnetii. Human infections are primarily attributed 
to sheep and goats (Delsing and Kullberg, 2008) but 
rarely to cattle (Hellenbrand et al., 2001). In 6 out of 40 
Q fever outbreaks in humans between 1944 and 1999 in 
Germany, the suspected source was cattle (Hellenbrand 
et al., 2001). The effect of an animal species on the 
transmission of Q fever to humans presumably depends 
on the main types of exposure to an animal species in 
a population, and the infection rate of these animals 
(Bernard et al., 2012). Risk factors associated with 
seropositivity include veterinarian procedures such as 
cattle obstetrics (Bernard et al., 2012), breeding cattle, 
and any job contact with waste from beef cattle or 
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goats (Whitney et al., 2013). Cattle are frequently per-
sistently infected, and persistent infection is associated 
with elevated seroactivity (Guatteo et al., 2007).
In most species, Q fever infection is asymptomatic 
and can last for a lifetime (Garcia-Ispierto et al., 2014). 
In humans, symptoms are usually flu-like, thus often 
leading to delayed or misdiagnoses and underestima-
tion of cases (Taurel et al., 2014). In more severe cases, 
Q fever causes abortion, endocarditis, hepatitis, and 
osteoarticular infection (Parker et al., 2006). In cattle 
around the world, animal (15 to 20%) and herd (38 to 
72%) level prevalence of C. burnetii is high (Guatteo 
et al., 2011). In a German study intensively screening 
dairy farms in Bavaria, sero- and herd prevalences of 
C. burnetii were 14.8 ± 0.48% and 72.3 ± 3.6%, respec-
tively (Böttcher et al., 2011). Yet, Q fever symptoms 
described in the literature have so far been inconsistent 
(Guatteo et al., 2011). Infertility, abortion (Bildfell et 
al., 2000), metritis, and mastitis (Arricau-Bouvery and 
Rodolakis, 2005; Barlow et al., 2008) were commonly 
reported. The presence of C. burnetii in dairy herds has 
not been clearly demonstrated to negatively affect re-
productive performance, and the infection mechanism 
remains unknown (López-Gatius et al., 2012; Garcia-
Ispierto et al., 2013, 2014).
Recently, the importance of Q fever prevention and 
control were emphasized by outbreaks in the Nether-
lands between 2007 and 2010 that infected more than 
3,500 humans and led to 7 deaths (van der Hoek et al., 
2010). Two main strategies can be used to control and 
prevent the disease: nonmedical and medical strategies. 
Nonmedical strategies are mostly hygiene related and 
focus on the time around parturition as ruminants have 
been reported to shed large loads of the bacteria at that 
time (Berri et al., 2002). Their efficiency is poorly doc-
umented in the literature (Taurel et al., 2014). Medical 
strategies include antibiotic therapy and vaccination. 
Antibiotic therapy is mainly based on the use of tetra-
cyclines. However, the efficacy of tetracycline to reduce 
shedding is inconsistent (Durand, 1993; Taurel et al., 
2012; Taurel et al., 2014), and a blanket treatment is 
not in accordance with a prudent use of antibiotics. It 
has been demonstrated, however, that a phase I vaccine 
is effective to prevent shedding at calving when ad-
ministered to noninfected animals such as nulliparous 
animals (Guatteo et al., 2008) and to reduce shedding 
in infected animals at calving (Arricau-Bouvery et al., 
2005). Most recently, it has been reported that a phase 
I vaccine is effective to reduce the prevalence of animal 
shedding the bacteria, bacterial load shed in cows (Tau-
rel et al., 2014), and abortion (Arricau-Bouvery et al., 
2005). Vaccination also may increase the likelihood of 
pregnancy by 1.25 (López-Helguera et al., 2013).
Phase I C. burnetii inactivated vaccine (Coxevac, 
Ceva Santé Animale, Libourne, France) against Q fever 
has been conditionally licensed in the European Union 
since 2010 and was granted full registration in 2015. 
Vaccines prepared from phase I C. burnetii organisms 
(virulent phase) are more protective against Q fever 
in laboratory animals than those prepared from phase 
II bacteria (Arricau-Bouvery et al., 2005). For goats, 
swelling at the injection site, increased body tempera-
ture, and decreased milk production after vaccination 
are described by the manufacturer (Ceva, 2012). For 
cows, only swelling at the injection site was reported 
by the manufacturer. Although anecdotal evidence is 
available of fever and decreased milk yield in some 
dairy cows after vaccination, science-based information 
is not available. Therefore, the objective of this study 
was to determine the effect of the vaccine on body 
temperature, milk yield, and injection site reactions in 
dairy cows.
MATERIALS AND METHODS
Two experiments were conducted to evaluate the 
effect of an inactivated phase I vaccine against C. bur-
netii on body temperature and milk yield after first 
vaccination. In both experiments, a commercial vaccine 
was used (Coxevac, Ceva Santé Animale, Libourne, 
France). Each vaccinal dose of 4 mL contained puri-
fied corpuscular antigens of phase I C. burnetii (100 
g/mL) inactivated by formaldehyde. Components of 
the vaccine are thiomersal, sodium chloride, disodium 
hydrogen phosphate, potassium dihydrogen phosphate, 
and water for injections. Coxevac does not contain any 
adjuvants.
The first experiment was conducted in August and 
September 2014 at the Clinic of Animal Reproduc-
tion, Freie Universität Berlin, Germany (52°25c37ccN, 
13°14c14ccE). A total of 10 clinically healthy Holstein 
dairy cows were used. They were housed in a freestall 
barn with cubicles, bedded with a mix of chopped straw 
and lime. Animals were fed twice daily with grass, si-
lage, concentrate, and hay. Serostatus of all cows was 
determined using an indirect ELISA (LSIVet Ruminant 
Q Fever, Life Technologies Corporation, Carlsbad, 
CA). A serum sample was considered as negative for 
antibodies against C. burnetii when the optical density 
as a percentage of a positive control (% optical density, 
OD%) was ≤40. A serum sample was considered as 
positive for antibodies against C. burnetii when OD% 
was >40. All cows were negative except one that was 
questionable.
The cows were randomly divided into 2 groups by use 
of a random treatment allocation plan generated before 
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initiation of the trial with the random number func-
tion of Excel (version 2013, Microsoft Corp., Redmond, 
WA). Group I (n = 5) was vaccinated and group II (n 
= 5) served as the control. Two weeks later, group II 
was vaccinated and group I served as the control group. 
The vaccination was administered subcutaneously with 
a disposable needle (21 ga × 1.5) in the neck. Animals 
were re-vaccinated 21 d after first vaccination. Cows in 
the control group remained untreated.
Temperature data loggers (DST micro-T, Star:Oddi, 
Gardabaer, Iceland) were attached to a modified 
controlled internal drug release device without pro-
gesterone (CIDR, InterAg, Hamilton, New Zealand) 
as previously described and validated (Burfeind et al., 
2011; Geiser et al., 2014). The devices were inserted 
into the vaginal cavity of vaccinated and control cows 
1 d before first and second vaccination, respectively. 
Temperature was measured every 15 min for 92 to 96 h. 
Afterward, loggers were removed and data were down-
loaded. For further analyses, hourly means, and means 
for 6 and 12 h, respectively, were calculated for every 
cow independently. Vaginal temperatures below 38.0°C 
were considered as artifacts due to loss or movement 
of the temperature logger and excluded from further 
analysis (Burfeind et al., 2011). All cows were clinically 
examined every morning from 1 d before vaccination 
until 3 d after vaccination. Examination included in-
spection of behavior, overall attitude, measurement of 
rectal temperature, and examination of injection sites. 
Investigators were blinded to the treatment group.
Ambient temperature (°C) and relative humidity 
(RH, %) within the barn were recorded hourly using a 
Tinytag Plus II logger (Gimini Loggers Ltd., Chichester, 
West Sussex, UK), which was secured at a beam 2.50 
m from the ground within the barn. The temperature 
humidity index (THI) was calculated according to the 
equation reported by Kendall et al. (2008): THI = (1.8 
× T + 32) – [(0.55 – 0.0055 × RH) × (1.8 × T – 26)].
The second experiment was conducted in Septem-
ber and October 2014 on a commercial dairy farm in 
Mecklenburg-Vorpommern, Germany (53°50c44ccN, 
13°14c40ccE) milking a total of 1,200 dairy cows. Four 
hundred ninety-eight lactating Holstein cows (239 pri-
miparous, 259 multiparous) were included. The cows 
were housed in 2 freestall barns with cubicles bedded 
with straw and fed a TMR 2 times a day. Cows were 
milked twice daily in a 50-stall rotary milking parlor 
(DeLaval, Tumba, Sweden). Individual milk yield was 
recorded for each milking from 7 d before vaccination 
(d −7) through 7 d after vaccination (d +7). Milk pro-
duction data were captured using an on-farm comput-
erized application that recorded milk production and 
herd management information (Herde, dsp-Agrosoft, 
Paretz, Germany).
The cows were randomly divided into 2 groups using 
the European cow registration number, whereby even-
numbered cows were vaccinated and odd-numbered 
cows were kept as controls. Group I (n = 246) was vac-
cinated and group II (n = 252) served as an untreated 
control. Vaccination, dosage, and application were 
identical as described in experiment 1. Animals were re-
vaccinated 21 d after first vaccination. Serostatus was 
assessed as described in experiment 1. One hundred 
seventy-five cows were positive (35%), and 323 cows 
were negative (65%).
Data were statistically analyzed with SPSS (version 
22, IBM, Ehningen, Germany). Differences in vaginal 
(experiment 1) or rectal temperature (experiment 2) 
before and after vaccination were determined with a 
paired t-test comparing the corresponding values in 
each group. An independent samples t-test was used 
to investigate the differences in temperature between 
vaccination and control groups. To study the effect of 
vaccination on milk yield, a repeated measure analysis 
was performed in a GLM framework using SPSS. To 
test whether the milk production response to the treat-
ment depended on the initial level of milk production 
(7 d before vaccination) of the subjects, 3 groups were 
built based on the average milk yield 7 d before vac-
cination (group A: 9.0–25.2 kg/d; group B: 25.3–30.6 
kg/d; group C: 30.7–47.6 kg/d). Cows with more than 
4 missing milk recordings were excluded from the 
analysis (n = 265). To determine the effect of vac-
cination on milk production, we evaluated the daily 
milk yield over the study period (i.e., d −7 until d 
+7) and the cumulative milk loss (δMY). Therefore, 
δMY was calculated by subtracting the cumulative 7 
d milk yield after vaccination (i.e., d +1 until d +7) 
from the cumulative milk yield before vaccination (i.e., 
d −1 until d −7). Subsequent analysis of the effect of 
vaccination on δMY was performed by GLM. Fixed 
effects were vaccination (yes, no), initial level of milk 
production (group A, group B, group C), C. burnetii 
serostatus before vaccination (positive/negative), and 
lactation group (primiparous; multiparous). Addition-
ally a 3-way interaction was built with vaccination, 
initial level of milk production, and C. burnetii se-
rostatus before vaccination. Initially, we also consid-
ered pregnancy status (pregnant vs. nonpregnant) at 
vaccination in the model. However, when tested in an 
univariate model as a fixed factor, no association was 
found with δMY (P = 0.611). Therefore, we excluded 
this factor from the final analysis as described previ-
ously (Dohoo et al., 2009).
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Rectal temperature was measured in a subset of 41 
cows (24 primiparous, 17 multiparous) immediately be-
fore vaccination and 24, 32, and 48 h after vaccination 
with a digital thermometer (Microlife VT 1831, Micro-
life AG, Widnau, Switzerland) as previously described 
(Burfeind et al., 2010). Fourteen cows were seropositive 
(34%) and 27 cows seronegative (66%). Ambient tem-
perature and RH were recorded accordingly to experi-
ment 1. The THI was calculated as described above.
RESULTS
Daily ambient temperatures (mean ± SD) were 19.3 
± 2.3°C and 17.7 ± 2.7°C in experiments 1 and 2, re-
spectively. Daily THI were 65.3 ± 3.3 and 63.3 ± 4.3, 
respectively.
In experiment 1 (Table 1), basal vaginal tempera-
tures of cows in group I and group II were similar (P 
= 0.599). Mean vaginal temperature of the vaccinated 
cows increased by 1.0°C within 12 to 24 h after treat-
ment (P = 0.005). Seven out of 10 (70%) vaccinated 
animals were febrile (temperature ≥39.5°C) 11.1 ± 
2.6 h (mean ± SD) after the vaccination. The vaginal 
temperature of febrile cows remained elevated for 3.0 
to 46.8 h and reached its maximum of 41.3°C 4.3 ± 4.2 
h (mean ± SD) after the vaccination. The difference 
of mean vaginal temperatures between vaccinated and 
control cows was 0.4°C (P = 0.009), 1.1°C (P = 0.002), 
and 0.4°C (P = 0.029) 0 to 12 h, 12 to 24 h, and 24 to 
36 h after vaccination, respectively. Within the control 
group, the mean vaginal temperature did not differ be-
tween the times of measurements. One control cow had 
to be excluded from temperature analysis because of 
the development of fever (body temperature ≥39.5°C) 
before time of vaccination. Three of the vaccinated 
cows showed a painful swelling of the skin at the injec-
tion site that had a maximum size of 14.0 × 14.0 × 1.1 
cm. The swelling appeared in 2 cows at the first day 
after vaccination and in 1 cow at the third day after 
vaccination. Swellings disappeared within a few days.
In experiment 2 (Table 1), basal rectal temperature 
of cows (i.e., before vaccination) in both groups was 
also similar (P = 0.172). Mean rectal temperature of 
vaccinated cows increased by 0.7°C (P = 0.001) after 
vaccination. Ten out of 21 (48%) vaccinated animals 
were febrile. The maximum body temperature of vac-
cinated cows was 41.8°C. No difference was observed 
in mean rectal temperature in the control group be-
tween basal values and the day after vaccination. The 
mean rectal temperature of vaccinated cows was 0.6°C 
higher (P = 0.003) than the mean rectal temperature 
of control animals on the first day after vaccination and 
0.3°C higher on the second day after vaccination (P = 
0.018), respectively. One cow in the control group had 
to be excluded from temperature analysis because of 
the development of fever (body temperature ≥39.5°C) 
before time of vaccination.
Milk production (kg/d) of cows in both groups was 
similar (not vaccinated, 28.4 ± 0.42; vaccinated, 28.2 
± 0.42; P = 0.826) before vaccination (Table 2). Vac-
Table 1. Body temperature (°C; mean ± SD, 75th percentile) of vaccinated and not vaccinated cows before (baseline) and after vaccination
Time relative to vaccination
Vaccinated
 
Not vaccinated
Mean ± SD 75th percentile Mean ± SD 75th percentile
Experiment 1 n = 10  n = 8
 0–12 h before (baseline) 38.4 ± 0.4a 38.5  38.4 ± 0.1a 38.5
 12–24 h after vaccination 39.4 ± 0.8b 40.2  38.3 ± 0.2a 38.5
Experiment 2 n = 21  n = 19
 Before vaccination 38.5 ± 0.2c 38.6  38.5 ± 0.3c 38.6
 Day after vaccination 39.1 ± 0.8d 39.5  38.5 ± 0.3c 38.8
a–dMeans within a row with different superscripts differ (P < 0.05).
Table 2. Descriptive statistics of Holstein cows enrolled in experiment 2
Item
Vaccinated 
(n = 252)
Not vaccinated 
(n = 246)
Primiparous cows, no. (%) 115 (45.6) 124 (50.5)
Multiparous cows, no. (%) 137 (54.4) 122 (49.5)
DIM at vaccination (± SEM) 164.2 (±6.10) 165.7 (±6.07)
Average daily milk yield before vaccination, kg/d (± SEM) 28.2 (±0.41) 28.4 (±0.43)
Average daily milk yield after vaccination, kg/d (± SEM) 26.8 (±0.39)a 28.2 (±0.44)b
Seronegative, no. (%) 156 (61.9) 167 (67.9)
Seropositive, no. (%) 96 (38.1) 79 (32.1)
a,bMeans within a row with different superscripts differ (P < 0.05).
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cinated cows produced less milk after vaccination (not 
vaccinated, 28.2 ± 0.44; vaccinated, 26.8 ± 0.39; P = 
0.033). The cumulative milk loss after vaccination was 
significantly influenced by vaccination (P = 0.001) and 
lactation group (P = 0.001). A tendency was found for 
the 3-way interaction of vaccination, serostatus, and 
milk production group (P = 0.086). Seronegative cows 
with the highest milk production had the highest cu-
mulative milk loss (Table 3; Figures 1 to 4).
DISCUSSION
Convincing evidence is available that body tempera-
ture is a useful and sensitive parameter to study the 
reactions of animals to physiological functions (e.g., 
nutrition, lactation, and reproduction), environmen-
tal challenges, and disease processes (Nakamura and 
Shimizu, 1983). An increase of body temperature as a 
side effect of vaccinations against bacterial and viral 
Table 3. Effect of a Coxiella burnetii vaccination and serostatus before vaccination on cumulative milk loss 
(means ± SEM) considering pretreatment milk yield (means ± SEM)
Group  Serostatus
Average daily milk  
yield before  
vaccination, kg/d No.
Cumulative milk  
loss 7 d after  
vaccination, kg
Control Negative 21.1 ± 0.37 59 1.2 ± 2.34
27.8 ± 0.23 51 −4.1 ± 2.50
36.3 ± 0.53 57 −2.1 ± 2.39
Positive 22.8 ± 0.51 24 −1.0 ± 3.68
27.9 ± 0.27 33 −3.9 ± 3.14
36.0 ± 1.03 22 −1.1 ± 3.84
Treatment Negative 21.6 ± 0.50 44 −8.2 ± 3.00
28.1 ± 0.20 49 −11.8 ± 2.86
35.4 ± 0.46 62 −17.7 ± 2.54
Positive 20.5 ± 0.63 39 0.0 ± 3.20
27.7 ± 0.27 32 −5.2 ± 3.54
34.7 ± 0.67 25 −8.8 ± 4.00
Figure 1. Mean daily milk yields (±SEM; n = 498) in vaccinated () and nonvaccinated () Holstein cows 7 d before to 7 d after first vac-
cination with an inactivated Coxiella burnetii vaccine.
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Figure 2. Effect of an inactivated Coxiella burnetii vaccine on cumulative milk loss (mean ± SEM) 7 d after first vaccination (n = 498) 
considering 3 pretreatment milk production levels. (A) 9.0 to 25.2 kg/d, open box; (B) 25.3 to 30.6 kg/d, shaded box; (C) 30.7 to 47.6 kg/d, 
black box.
Figure 3. Effect of Coxiella burnetii serostatus on cumulative milk loss (mean ± SEM) 7 d after first vaccination in vaccinated animals (n 
= 252) considering 3 pretreatment milk production levels. (A) 9.0 to 25.2 kg/d, open box; (B) 25.3 to 30.6 kg/d, shaded box; (C) 30.7 to 47.6 
kg/d, black box.
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pathogens has been documented. After administration 
of two 9-way vaccines to 164 cows, a significant increase 
(P = 0.001) in mean temperature of vaccinated animals 
between d 0 and 1 occurred (Scott et al., 2001). Mean 
temperature of vaccinated cows was significantly higher 
on d 1 compared with control cows (vaccine 1: 0.41°C; 
vaccine 2: 0.29°C). Also, an inactivated bovine her-
pesvirus 1 vaccine tested in 455 lactating cows in the 
Netherlands caused a significant increase (0.45°C) in 
body temperature (Bosch et al., 1997). In both studies, 
reporting of the temperature measurement was unclear. 
Whereas in the first study temperature was measured 
electronically once a day from 2 d before until 10 d 
after vaccination (Bosch et al., 1997), in the second 
study no details were provided at all except that mea-
surements were rectal (Scott et al., 2001). To closely 
study relationships between changes in temperature 
and vaccination, we used devices logging the vaginal 
temperature every 15 min from 1 d before to 92 to 96 h 
after vaccination in experiment 1. In both studies, body 
temperature was measured with rectal thermometry 3 
times in 2 d in experiment 1 and immediately before 
vaccination and 24, 32, and 48 h after vaccination in 
experiment 2, respectively. We found a significantly 
elevated body temperature after vaccination in both 
experiments of the present study. Seventy and 48 per-
cent of vaccinated cows developed fever in experiments 
1 and 2, respectively.
Body temperature is influenced by heat stress during 
different stages of lactation (Hahn, 1999; Kadzere et 
al., 2002; Mader et al., 2006). A THI of 72 equivalent 
to 25°C ambient temperature and 50% relative humid-
ity is generally accepted as the upper threshold of the 
comfort zone for cattle (Igono et al., 1992; West et al., 
2003; Kendall et al., 2006). In the present study, aver-
age daily THI were 65.3 ± 3.3 and 63.3 ± 4.3 (mean ± 
SD), respectively. Therefore, we can exclude an influ-
ence of THI on body temperature in our data.
The lower proportion of febrile cows and the smaller 
difference in temperature between vaccinated and con-
trol animals in experiment 2 compared with experiment 
1 are likely due to the different measurement methods. 
Whereas in experiment 1, body temperature was mea-
sured in the vagina every 15 min, in experiment 2 body 
temperature was measured in the rectum 3 times in 2 
d. Thus, the experiments had differences in frequency 
and site of measurement, and measurement device, re-
spectively. It is obvious, that through high frequency 
measurements the temperature profile will be detected 
more accurately and the risk to miss peak temperatures 
Figure 4. Effect of Coxiella burnetii serostatus on cumulative milk loss (mean ± SEM) 7 d after first vaccination in nonvaccinated animals 
(n = 246) considering 3 pretreatment milk production levels. (A) 9.0 to 25.2 kg/d, open box; (B) 25.3 to 30.6 kg/d, shaded box; (C) 30.7 to 
47.6 kg/d, black box.
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is reduced. Scott et al. (1998) suggested that a 24-h 
sampling interval from treatment administration until 
first post treatment measurement could be too long to 
detect pyrexic changes. In the present study, cows de-
veloped fever 11.1 ± 2.6 h (mean ± SD) after vaccina-
tion. The temperature of febrile cows remained elevated 
for 3.0 to 46.8 h. With a measurement frequency of 
once a day, only 3 out of 7 febrile cows would have 
been detected by rectal measurement. Regarding the 
device of measurement, it has been shown that rectal 
measures can be biased by intra-observer variability, 
penetration depth, and thermometer type (Burfeind et 
al., 2010). Temperature data of vaginal loggers can be 
influenced by logger movement resulting in the sensor 
end pointing to the external environment. According to 
Burfeind et al. (2011), we considered vaginal tempera-
tures below 38.0°C as artifacts due to loss or movement 
of the temperature logger and excluded those from 
further analysis. Thus, we do not expect an influence 
of logger movement or loss on our results. We assume 
that both measurement frequency and measurement 
method can explain the differences in temperature data 
between the 2 experiments. We do not assume that the 
different sites of measurement had an effect because the 
association between rectal and vaginal temperature us-
ing identical loggers is high and the difference negligible 
(Suthar et al., 2013).
Milk production can be also considered as a physi-
ological function of lactating dairy cattle sensitive to 
stressors. Therefore, we evaluated the effect of vacci-
nation on short-term changes in milk production. The 
cumulative milk loss after first vaccination was influ-
enced by an interaction between C. burnetii serostatus 
and average milk yield 7 d before first vaccination. 
High-producing cows testing negative for C. burnetii 
before first vaccination had the highest cumulative milk 
loss 1 wk after vaccination. Although several studies 
report a negative effect of vaccination on short-term 
milk production for different kind of antigens (Musser 
and Anderson, 1996; Scott et al., 2001; Bergeron and 
Elsener, 2008), this is the first study showing an effect 
of a phase I C. burnetii inactivated vaccine. It was also 
reported before that milk loss in high-producing cows is 
more pronounced when a 9-way killed vaccine was used 
(Scott et al., 2001). To our knowledge, this is the first 
study showing an effect of C. burnetii serostatus before 
vaccination on the physiological response in vaccinated 
lactating dairy cows. The physiological response in an 
animal naive to the inactivated phase I antigen of C. 
burnetii seems to be more pronounced compared with a 
seropositive animal.
In both experiments of this study, control animals 
remained untreated. Several vaccination trials included 
a placebo-treated control group. Some inactivated vac-
cines contain adjuvants that are well known to cause side 
effects (Gethmann et al., 2009). In those cases, it makes 
sense to include placebo-treated animals that receive an 
injection of adjuvant containing the carrier or saline to 
compare whether the vaccine antigens or the adjuvant 
causes the effects. Coxevac did not contain any adju-
vant. Therefore, we refrained from a placebo treating 
of the control cows. The principal difference between a 
no-treatment controlled trial and a placebo-controlled 
trial is that subjects and investigators are not blind 
to treatment assignment (Department of Health and 
Human Services, 1999). Vaccinated and untreated cows 
were restrained for the same time and thus the disrup-
tion of their feeding and social routines were identical. 
These actions should equally apply to the control and 
treatment group, even if it is not strictly necessary to 
deliver an untreated status.
Swelling of the injection site is an adverse event that 
is observed frequently after vaccination of cattle with 
different vaccines. Gethmann et al. (2009) investigated 
the safety of 3 different monovalent vaccines against 
blue tongue virus in 1,007 sheep and 893 cattle. The 
blue tongue virus vaccines were administered subcu-
taneously at the neck like the Coxiella vaccine in the 
present study. Short-term moderate swelling of the 
injection site was seen after the first vaccination only 
in 2 juvenile cows, but more frequently in adult cows. 
After the second vaccination, virtually all cows reacted 
with low-grade swelling. Significant differences in swell-
ing at the injection site between vaccinated and control 
animals was also reported in a study investigating the 
effect of a core antigen vaccine against gram-negative 
bacteria on physiologic and yield parameters of dairy 
cows (Scott et al., 1998).
Aside from differences in frequency of febrile cows and 
temperature differences between vaccinated and control 
animals, we found a moderate but significant, transient 
increase of body temperature in both experiments, 
temporary swelling of the injection site in experiment 
1, and a reduction in milk yield in experiment 2. Ris-
ing temperatures after vaccination can be interpreted 
as a physiological systemic reaction, which is common 
after the application of many vaccines (Gethmann et 
al., 2009). In conclusion, a transient increase of body 
temperature and decrease in milk yield is prevalent 
after Coxevac vaccination as part of the physiological 
immune response.
According to the manufacturer’s specification, initial 
immunization for C. burnetii with Coxevac should be 
completed 3 wk before first artificial insemination in 
heifers. Results from our study indicate that cows tested 
positive for C. burnetii did not show a pronounced side 
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effect on milk yield due to the initial immunization. 
Although not tested specifically, one can conclude that 
seroconversion in heifers due to primary vaccination 
might protect them from a marked physiological im-
mune response with negative effects on milk production 
when these animals are revaccinated during lactation. 
Therefore, to avoid negative effects of vaccination on 
milk production, we recommend initial immunization of 
heifers in agreement with the manufacturer`s specifica-
tion. This should be evaluated in further studies.
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